1 / 7

Asia-Pacific Plasma Therapy Market Overview

Meticulous Researchu00ae forecasts the Asia-Pacific plasma therapy market will reach $214 million by 2030, growing at a CAGR of 13.4%. Key growth drivers include rising healthcare expenditure, an aging population, and increased accident rates. However, stringent regulations pose challenges, while expanding applications offer opportunities.<br>

Prajwal26
Télécharger la présentation

Asia-Pacific Plasma Therapy Market Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. “Meticulous Research® Projects Asia- Pacific Plasma Therapy Market $214 Billion by 2030” pen_spark” J

  2. Asia-Pacific Plasma Therapy Market 2024-2030 Asia-Pacific Plasma Therapy Market Overview Meticulous Research®, a prominent global market research company, has released an insightful report titled “Asia-Pacific Plasma Therapy Market, By Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology, Stomatology), End User (Hospitals & Clinics, Research Institutes) - Forecast to 2030.” This report offers a comprehensive analysis of the plasma therapy market in the Asia-Pacific region, forecasting a significant growth trajectory driven by various socio-economic and healthcare-related factors. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample- report/cp_id=5556?utm_source=article&utm_medium=social&utm_campai gn=product&utm_content=10-10-2024 Market Dynamics Market Size and Growth Rate According to the latest research findings from Meticulous Research®, the Asia- Pacific plasma therapy market is projected to reach $214 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 13.4% from 2024 to 2030. This robust growth can be attributed to multiple factors influencing the healthcare landscape in the region. Key Growth Drivers 1.Increase in Healthcare Expenditure: The rising expenditure in healthcare across Asia-Pacific countries is a pivotal factor contributing to market growth. Governments and private sectors are investing in advanced medical technologies and treatments, including plasma therapy. 2.Growing Geriatric Population: The increasing elderly population is creating a higher demand for medical treatments, including regenerative therapies like platelet-rich plasma (PRP), which are beneficial for age- related conditions. Page 1 of 6 © Meticulous Research| sales@meticulousresearch.com

  3. Asia-Pacific Plasma Therapy Market 2024-2030 3.Rising Incidence of Accidents: A significant number of accidents in the region necessitate effective treatments, thereby boosting the demand for plasma therapy. 4.Promotion of PRP Usage: Conferences and research initiatives advocating for the benefits of PRP therapy are instrumental in raising awareness and acceptance of plasma treatments across various medical specialties. Market Challenges Despite the favorable growth conditions, the Asia-Pacific plasma therapy market faces challenges, notably the stringent regulatory framework governing the use of PRP. These regulations may hinder the rapid adoption of PRP therapies across different countries, necessitating adherence to safety and efficacy standards. Opportunities for Growth The market presents ample opportunities, particularly through: •Expanding Applications of PRP Treatments: As research continues to unveil new applications for PRP, including areas such as orthopedics and dermatology, the market is poised for expansion. •Advancements in Healthcare Infrastructure: Improvements in healthcare infrastructure across Asia-Pacific nations will enhance the delivery and accessibility of plasma therapies, thereby facilitating market growth. Market Segmentation The Asia-Pacific plasma therapy market is segmented based on type, application, end user, and geography. By Type The market is categorized into several types of plasma therapies: 1.Pure Platelet-rich Plasma (PRP): Expected to hold the largest market share in 2024 due to its preference as a point-of-care therapy, reducing the need for surgical interventions. Page 2 of 6 © Meticulous Research| sales@meticulousresearch.com

  4. Asia-Pacific Plasma Therapy Market 2024-2030 2.Platelet-rich Fibrin: Increasing adoption of this method for its regenerative properties in various medical applications. 3.Leukocyte-rich PRP: Gaining traction due to its enhanced healing properties, particularly in orthopedic and dermatological treatments. By Application The applications of plasma therapy are diverse, with significant segments including: •Orthopedics: Utilization in pain management and joint-related therapies. •Dermatology and Cosmetology: Expected to experience the highest CAGR over the forecast period, driven by the increasing prevalence of skin and hair disorders and a growing interest in aesthetic enhancements. •Rheumatology: Application in managing autoimmune and inflammatory conditions. •Ophthalmology and Stomatology: Emerging areas for PRP utilization. By End User The end-user segmentation highlights: •Hospitals and Clinics: Expected to dominate the market share in 2024, primarily due to the comprehensive application of PRP in trauma management, regenerative medicine, and cosmetic procedures. •Research Institutes: Engaged in advancing the scientific understanding and application of plasma therapy. Geographic Insights This report provides an in-depth analysis of major countries, including China, Japan, India, South Korea, Australia, Singapore, and the Rest of Asia-Pacific. 1.Japan: Anticipated to hold the largest share of the plasma therapy market in 2024, attributed to: oIncreasing awareness of PRP therapy. oA rise in road accidents necessitating effective treatments. Page 3 of 6 © Meticulous Research| sales@meticulousresearch.com

  5. Asia-Pacific Plasma Therapy Market 2024-2030 oGrowing interest in cosmetic procedures, particularly in response to the country’s declining fertility rates. The World Bank reported a decline in Japan’s fertility rate from 1.4 births per woman in 2019 to 1.3 births per woman in 2021. The adoption of PRP in infertility treatments, such as enhancing endometrial growth in IVF, is expected to further boost market demand. 2.China and India: Rapidly developing healthcare sectors and increasing investment in advanced medical treatments position these countries as key players in the market. 3.Australia and South Korea: These countries are experiencing significant growth in PRP applications across various medical fields, further driving market expansion. Competitive Landscape The Asia-Pacific plasma therapy market features several prominent players, including: •Arthrex, Inc. (U.S.) •DePuy Synthes, Inc. (Johnson & Johnson) (U.S.) •Global Stem Cells Group, Inc. (U.S.) •Terumo Corporation (Japan) •Regen Lab SA (Switzerland) •Stryker Corporation (U.S.) •Zimmer Biomet Holdings, Inc. (U.S.) •Exactech Inc. (U.S.) •Beijing Manson Technology Co., Ltd. (China) •Alocuro (Australia) •Takeda Pharmaceutical Company Limited (Japan) •Grifols, S.A. (Spain) •Octapharma AG (Switzerland) Page 4 of 6 © Meticulous Research| sales@meticulousresearch.com

  6. Asia-Pacific Plasma Therapy Market 2024-2030 •CSL Limited (Australia) Market Share Analysis The competitive analysis of the Asia-Pacific plasma therapy market showcases the distribution of market share among these key players, indicating a highly competitive environment with various strategies employed for market penetration, including: •Product Innovation: Companies are focusing on developing advanced PRP technologies and formulations to enhance efficacy and patient outcomes. •Strategic Partnerships and Collaborations: Collaborating with research institutions and healthcare providers to promote the use of PRP therapies and explore new applications. •Geographic Expansion: Expanding presence in emerging markets within the Asia-Pacific region to capture growth opportunities. Read Full Report - https://www.meticulousresearch.com/product/asia- pacific-plasma-therapy-market-5556 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Page 5 of 6 © Meticulous Research| sales@meticulousresearch.com

  7. Asia-Pacific Plasma Therapy Market 2024-2030 Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous- research Page 6 of 6 © Meticulous Research| sales@meticulousresearch.com

More Related